A senior vice president at Novo Nordisk, a leader in diabetes care, growth hormone therapy, hormone replacement therapy, and hemophilia care, Jesper Høiland is responsible for international operations in 150 countries. While Novo Nordisk is headquartered in Denmark, Høiland spends most of his time traveling around the world and visiting many of the emerging markets that make up a big part of his portfolio. He spends about 20 hours every week on an airplane, he says.
Here, Høiland discusses how more people today die from being overweight than from starvation, the time he wanted to be a footballer, and why it's important to step outside of the office and see things happening in person.
What do you say when people ask you, "What do you do?"
I like to think of myself as the hothouse of Novo Nordisk who determines where we'll expand the business and how. I find the plants, give them the seeds, the right water, the right sun, and see what comes out of it. I do this for all of our international operations in 150 countries in South America, Asia, the Middle East, and Africa.
An important component of my job is to draw the world's attention to the diabetes pandemic. Today, 366 million people worldwide have diabetes, and prevalence rates are growing fastest in developing countries and emerging markets. What is surprising is that the disease is not just a function of affluence and diet. More than 80 percent of people with diabetes live in low- and middle-income countries, but only 15 percent are diagnosed.
I will tell my grandchildren that I did not just sell insulin; I tried to make the world a better place and drove change in the parts of the world where people needed it most. Everybody wishes for good health and quality of life -- that is what we are basically trying to help people achieve.
What new idea or innovation is having the most significant impact on medicine?
I think the greatest innovation came in 1922 when Frederick Banting and Charles Best discovered insulin at the University of Toronto. This has changed life for so many people in the world. Before then, diabetes was really a death sentence.
Another great idea is our Base of the Pyramid project, in which Novo Nordisk is trying to change diabetes care for the roughly 1 billion people living on $3 to $10 a day. We recently committed to reach 2 million people with diabetes living at the Base of the Pyramid, which is not an easy task.
What's something that most people just don't understand about your area of expertise?
Why I spend more than 20 hours a week on a plane and what it is like to live out of a suitcase. My view is that you cannot sit in an ivory tower, office complex, or financial capital and know what is happening in the world. If you want to make business decisions, you have to be close to the market, live in that culture, and see it in person.
What's an emerging trend that you think will shake up the health world?
|Auden Schendler, Aspen's Green Guy|
|Allison Arieff, Writer and Editor on Sustainability|
|Charles R. Wolfe, Environmental Lawyer|
|Fred Kent, Leader in Revitalizing City Spaces|
It's fascinating that the world's largest collection of mobile phones are in China, India, and Africa, where many people lack access to running water and hospital beds. I think there is huge potential in mobile health technology to bring lifesaving medicines to people in the emerging markets and remote parts of the world.
At Novo Nordisk, we've created mobile applications for doctors to access information about insulin dosing and bleeding disorders, which helps them to better treat patients. We have an ongoing mobile technology project we're running in Gabon and I'm interested in seeing how that turns out. It's certainly a space where we want to experiment and innovate.
What's a health trend that you wish would go away?
Obesity and malnutrition are really frightening trends. Both are drivers of diabetes, but obesity presents a far greater threat.